Bullish Case: Mean reversion and ongoing buybacks support modest upside for EIG. The return surface shows positive drift for multi‑quarter holds, while the EIG IV surface remains elevated near term but often compresses as uncertainty fades. At about $43 with a ~3% 90–day gain, a 3–7% rise in 2–3 months is plausible, aided by reserve stability and book-value growth. Upcoming catalysts: 6/18/2026 expiry and continued buyback signals.

Bearish Case: Idiosyncratic CA exposure and persistent underwriting tail risk keep downside possible. The near‑term IV spike and potential reserve volatility hint at risk materialization if results disappoint. A -3% to -9% move in 2–3 months is plausible, with limited downside if buybacks persist but larger moves possible on adverse reserve development or macro shocks.

Potential Outcomes:

• 40%: +0–12% in 2–3 months. Rationale: mean reversion, ongoing buybacks, stable reserves.
• 20%: -4 to -10% in 2–3 months. Trigger: tail-risk event or weaker-than-expected Q2 results.
• 25%: +12 to +25% by 6–12 months. Catalyst: reserve releases, underwriting improvement, modest buyback expansion.
• 10%: >+30% in 12 months. Catalyst: larger-than-expected buyback/M&A or valuation re-rating on improved ROE.
• 5%: -15% or more in 6–12 months. Trigger: adverse reserve development or macro shock.

May 20, 2026